Lahmann Nils, Mayer Martha Feh, Posnett John
Geriatrics Research Group, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Medical School Berlin University, Rüdesheimer Str. 50, 14197 Berlin, Germany.
Open Med (Wars). 2024 Feb 13;19(1):20230839. doi: 10.1515/med-2023-0839. eCollection 2024.
Hospital-acquired pressure ulcers are an important indicator of the quality of care. Most pressure ulcers are avoidable with a robust protocol for prevention, but prevention activities often have a low priority for senior management because the true costs to the hospital are not visible. Our aim was to raise awareness of the value of pressure ulcer prevention by estimating the excess length of inpatient stay associated with hospital-acquired pressure ulcers, and by assessing whether additional costs are covered by increased reimbursement.
National activity data for hospitals in Germany are available through the InEK Data Browser. Data were extracted covering discharges from German hospitals between January 1 and December 31, 2021. Cases were selected according to the presence of a pressure ulcer diagnosis using ICD-10-GM codes L89.0-L89.3. Information was extracted for the ten most common German Diagnosis-Related Group (G-DRG) codes in patients with a secondary pressure ulcer diagnosis on mean length of stay and average reimbursement. Ulcer-associated excess length of stay was estimated by comparing cases within the same G-DRG with and without a pressure ulcer diagnosis.
Mean length of stay was higher in patients with a pressure ulcer than in patients with no ulcer by between 1.9 (all ages) and 2.4 days (patients aged ≥65) per case. In patients aged ≥65 years, 22.1% of cases with a pressure ulcer had a length of stay above the norm for the DRG. In the German system length of stay above the norm is not normally reimbursed. Excess length of stay between 1.9 and 2.4 days leads to a potential cost to a hospital of between 1,633€ and 2,074€ per case.
Hospital-acquired pressure ulcers represent an important source of cost for a hospital which highlights the potential value of effective prevention.
医院获得性压疮是护理质量的一项重要指标。通过强有力的预防方案,大多数压疮是可以避免的,但预防活动在高级管理层的工作优先级中往往较低,因为医院的实际成本并不明显。我们的目的是通过估计与医院获得性压疮相关的住院时间延长,并评估增加的报销费用是否能覆盖额外成本,来提高对压疮预防价值的认识。
德国医院的全国活动数据可通过InEK数据浏览器获取。提取了2021年1月1日至12月31日期间德国医院出院的数据。根据使用ICD-10-GM编码L89.0-L89.3的压疮诊断情况选择病例。提取了患有继发性压疮诊断的患者中十个最常见的德国诊断相关组(G-DRG)编码的平均住院时间和平均报销信息。通过比较同一G-DRG组中有和没有压疮诊断的病例,估计溃疡相关的住院时间延长。
有压疮的患者平均住院时间比无压疮的患者长,每例患者多1.9天(所有年龄段)至2.4天(≥65岁患者)。在≥65岁的患者中,22.1%有压疮的病例住院时间超过了DRG的标准。在德国系统中,超过标准的住院时间通常不予报销。1.9至2.4天的住院时间延长会给医院带来每例1633欧元至2074欧元的潜在成本。
医院获得性压疮是医院成本的一个重要来源,这凸显了有效预防的潜在价值。